circumsporozoite protein

What are the Challenges in Developing CSP-based Vaccines?

Despite the promise of CSP as a vaccine target, several challenges exist:
- Genetic variability: The CSP gene exhibits considerable genetic diversity among different Plasmodium strains, which can affect the efficacy of the vaccine.
- Immune evasion: The parasite has evolved mechanisms to evade the host's immune system, complicating vaccine development.
- Durability of protection: The longevity of the immune response elicited by CSP-based vaccines remains a concern, necessitating booster doses to maintain protection.

Frequently asked queries:

Partnered Content Networks

Relevant Topics